Mainly engaged in clinical research of new drugs, introduction or transfer of new drug technology projects, and responsible for reporting and registering drugs to the US FDA.
Service Hotline: 400-828-3900
E-mail of adverse reaction complaint: firstname.lastname@example.org
Company address: No. 7 Kunlunshan Road, Lianyungang Economic and Technological Development Zone, Jiangsu Province